AzTrials
AzTrials

HealthyNCT07663019

Chatbot Intervention Effects on Belief Updating in Anhedonia

A study testing MI Chatbot Interaction in people with Healthy, run by University of Electronic Science and Technology of China at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The main aim of the present study is to investigate the effects of a Motivational Interviewing-based artificial intelligence chatbot on belief updating in college students with elevated levels of depression and anhedonia by combining a randomized active-control intervention design with pre- and post-intervention… Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
MI Chatbot Interaction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteChina
Study dates
20 Jun 2026to 31 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-40 years
  • Right-handed
  • Normal or corrected normal visual acuity
  • Participants must show elevated anhedonia and depressive symptoms at screening, defined as a total score of 22 or higher on the Snaith-Hamilton Pleasure Scale and a score of 14 or higher on the Beck Depression Inventory

Who cannot join

  • History of major central nervous system disorders, such as epilepsy, traumatic brain injury, stroke, or brain tumors.
  • History of severe mental illness, including schizophrenia spectrum disorders, bipolar disorder, or other psychotic disorders.
  • History of substance or alcohol use disorder or substance or alcohol misuse within the past 12 months that may affect study participation or outcome assessment.
  • Individuals currently at high risk of suicide, severe self-harm, or experiencing an acute psychiatric crisis.
  • Individuals who are currently using psychiatric medications or have undergone psychotherapy within the past 4 weeks that may significantly affect mood, motivation, or reward processing.
  • Severe vision or hearing impairments that cannot be corrected and would interfere with task performance.
  • Contraindications to MRI scanning, including metallic implants, pacemakers, severe claustrophobia, or other conditions incompatible with MRI.
  • Pregnancy or breastfeeding.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Benjamin Becker, Dr contact

(852) 3917-5097

bbecker@hku.hk

China1 site, 1 recruiting
  • University of Electronic Science and Technology of China

    Chengdu, Sichuan

    Recruiting

Other trials in China

About this study

Official title: Effects of a Chatbot-Based Intervention on Valence-Dependent Belief Updating and Expectancy Bias for Life Events in Individuals With Anhedonia

The main aim of the present study is to investigate the effects of a Motivational Interviewing-based artificial intelligence chatbot on belief updating in college students with elevated levels of depression and anhedonia by combining a randomized active-control intervention design with pre- and post-intervention behavioral belief updating task assessments.

Read the detailed description

Anhedonia represents a core characteristic of depression and is characterized by reduced experience of pleasure. It is closely related to decreased motivation, altered reward processing, changes in affective responsiveness, and alterations in intrinsic brain network function. Anhedonia is not specifically targeted by currently available pharmacological interventions. Initial evidence indicates that an increased willingness to change and implementation of change in daily life can alleviate anhedonia.

The present study aims to examine whether a Motivational Interviewing-based AI chatbot can lead to changes in belief updating in college students with elevated anhedonia and depressive symptoms. Belief updating is included because anhedonia and depressive symptoms may be associated with biased or inflexible use of new information, which may influence future expectations, motivation, and engagement in rewarding activities. The belief updating task allows the study to examine how participants revise their expectations after receiving new information. To this end, eligible participants with a total score of 22 or higher on the Snaith-Hamilton Pleasure Scale and a score of 14 or higher on the Beck Depression Inventory will undergo a randomized, between-subjects, active-control intervention study. Participants will be assigned to either a Motivational Interviewing-based chatbot group or an active control chatbot group for 1 week. Pre- and post-intervention assessments will include self-report questionnaires and a behavioral belief updating task to examine psychological and behavioral effects of the intervention.

Conditions
Healthy
Being tested
MI Chatbot Interaction, Active Control Chatbot Interaction
Keywords
fMRI, AI Interaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MI Chatbot InteractionBehavioural

    The experimental chatbot is designed to use principles of Motivational Interviewing to support participants in exploring their personal values, motivation for change, and daily behavioral goals related to pleasure, engagement, and reward-seeking. During the intervention period, participants will interact with the chatbot regularly through brief text-based conversations. The chatbot will provide empathic, non-judgmental responses, encourage reflection on current difficulties, and help participants identify small, feasible actions that may increase daily engagement and positive experiences. It will not provide diagnosis, crisis counseling, or medical treatment.

  • Active Control Chatbot InteractionBehavioural

    Participants will interact with a chatbot matched in format and frequency of use. This chatbot will provide neutral nature-related stories or general natural history content. It will be designed to maintain participant engagement while avoiding therapeutic techniques, motivational interviewing strategies, behavioral activation guidance, or personalized mental health advice. This active control condition will help control for nonspecific effects of chatbot interaction, attention, expectancy, and digital engagement.

Study groups in NCT07663019
Study groupRoleWhat they receive
Motivational Interviewing-based AI chatbot groupExperimentalMotivational Interviewing-based AI chatbot intervention
Receives: Behavioral: MI Chatbot Interaction
Active control chatbot groupActive comparatorActive control nature-story chatbot intervention
Receives: Behavioral: Active Control Chatbot Interaction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Valence-dependent belief updating bias

    Belief updating magnitude will be calculated separately for positive and negative information conditions in the belief updating task before and after the intervention. Updating magnitude will be quantified based on changes in probability estimates before and after the presentation of new information. The difference in updating magnitude between positive and negative information conditions will be calculated and compared from baseline to post-intervention.

    Measured: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.

Secondary outcomes (1)
  1. Expectancy bias for life events

    Before receiving base-rate information or new information, participants will provide initial probability estimates for positive and negative life events at baseline and post-intervention. Mean initial estimates will be calculated separately for the two event types, and pre-to-post changes in the difference between positive and negative event estimates will be compared.

    Measured: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2026
  2. Study start20 Jun 2026 (estimated)
  3. Primary completion30 Jun 2028 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Between-subject randomized controlled trial comparing a Motivational Interviewing-based AI chatbot intervention with an active control chatbot intervention.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07663019
Sponsor's protocol ID
BAM_lab_MI_05
Status last verified
Jun 2026
First submitted
17 Jun 2026
Last updated
9 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Corresponding individual level data will be made available upon request.

Questions about this trial

What is this clinical trial studying?

A study testing MI Chatbot Interaction in people with Healthy, run by University of Electronic Science and Technology of China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Benjamin Becker, Dr ((852) 3917-5097, bbecker@hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Valence-dependent belief updating bias (time frame: Baseline before the first chatbot interaction and Week 1 after completion of the chatbot intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in